Phocas Financial Corp’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,588
| Closed | -$1.93M | – | 145 |
|
|
2025
Q1 | $1.93M | Sell |
16,588
-958
| -5% | -$112K | 0.3% | 105 |
|
|
2024
Q4 | $1.49M | Sell |
17,546
-155
| -0.9% | -$13.1K | 0.2% | 119 |
|
|
2024
Q3 | $1.59K | Sell |
17,701
-1,098
| -6% | -$99 | 0.01% | 134 |
|
|
2024
Q2 | $1.51K | Sell |
18,799
-355
| -2% | -$29 | 0.01% | 129 |
|
|
2024
Q1 | $1.53K | Sell |
19,154
-7,736
| -29% | -$617 | 0.01% | 136 |
|
|
2023
Q4 | $2.14M | Buy |
+26,890
| New | +$2.14M | 0.28% | 114 |
|